共 50 条
- [31] A phase Ib/II trial of lenvatinib (LEN) plus pembrolizumab (Pembro) in patients (Pts) with endometrial carcinoma.JOURNAL OF CLINICAL ONCOLOGY, 2017, 35Makker, Vicky论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USARasco, Drew W.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USADutcus, Corina E.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USAStepan, Daniel E.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USALi, Di论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USASchmidt, Emmett V.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USAShumaker, Robert Charles论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USATaylor, Matthew H.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
- [32] Phase 1b study of futibatinib plus pembrolizumab in patients with esophageal carcinoma: Evaluating the immunological effects.JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 477 - 477Kojima, Takashi论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, JapanShinohara, Hajime论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, JapanEguchi, Susumu论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, JapanIzawa, Naoki论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, JapanChin, Keisho论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, JapanTanaka, Yoshihiro论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, JapanMachida, Nozomu论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, JapanIwatsuki, Masaaki论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, JapanIijima, Katsunori论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, JapanHorita, Yosuke论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, JapanSatoh, Taroh论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, JapanOjima, Hitoshi论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, JapanMitani, Seiichiro论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, JapanNishino, Kazumi论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, JapanHirai, Hiroshi论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, JapanMizutani, Hiroya论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, JapanChisamore, Michael Jon论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, JapanMinashi, Keiko论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Japan
- [33] Characterization of Tumor Responses in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib in the Phase 3 Randomized Trial: REFLECTLIVER CANCER, 2024, 13 (05) : 537 - 547Finn, Richard S.论文数: 0 引用数: 0 h-index: 0机构: UCLA, David Geffen Sch Med, Dept Med,Med Ctr, Div Hematol Oncol, Los Angeles, CA 90095 USA UCLA, David Geffen Sch Med, Dept Med,Med Ctr, Div Hematol Oncol, Los Angeles, CA 90095 USAQin, Shukui论文数: 0 引用数: 0 h-index: 0机构: Chinese PLA Canc Ctr, Nanjing Bayi Hosp, Nanjing, Peoples R China UCLA, David Geffen Sch Med, Dept Med,Med Ctr, Div Hematol Oncol, Los Angeles, CA 90095 USAPiscaglia, Fabio论文数: 0 引用数: 0 h-index: 0机构: IRCCS Azienda Osped Univ Bologna, Div Internal Med Hepatobiliary & Immunoallerg Dis, Bologna, Italy Univ Bologna, Dept Med & Surg Sci, Bologna, Italy UCLA, David Geffen Sch Med, Dept Med,Med Ctr, Div Hematol Oncol, Los Angeles, CA 90095 USAEvans, Thomas R. Jeffry论文数: 0 引用数: 0 h-index: 0机构: Univ Glasgow, Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland UCLA, David Geffen Sch Med, Dept Med,Med Ctr, Div Hematol Oncol, Los Angeles, CA 90095 USAKnox, Jennifer J.论文数: 0 引用数: 0 h-index: 0机构: Princess Margaret Canc Ctr, Toronto, ON, Canada UCLA, David Geffen Sch Med, Dept Med,Med Ctr, Div Hematol Oncol, Los Angeles, CA 90095 USALopez Lopez, Carlos论文数: 0 引用数: 0 h-index: 0机构: Marques de Valdecilla Univ Hosp, Dept Med Oncol, Santander 39008, Cantabria, Spain UCLA, David Geffen Sch Med, Dept Med,Med Ctr, Div Hematol Oncol, Los Angeles, CA 90095 USARamji, Zahra论文数: 0 引用数: 0 h-index: 0机构: Eisai Inc, Med Affairs, Nutley, NJ USA UCLA, David Geffen Sch Med, Dept Med,Med Ctr, Div Hematol Oncol, Los Angeles, CA 90095 USARen, Min论文数: 0 引用数: 0 h-index: 0机构: Eisai Inc, Biostat, Nutley, NJ USA UCLA, David Geffen Sch Med, Dept Med,Med Ctr, Div Hematol Oncol, Los Angeles, CA 90095 USAMody, Kalgi论文数: 0 引用数: 0 h-index: 0机构: Eisai Inc, Clin Res, Nutley, NJ USA UCLA, David Geffen Sch Med, Dept Med,Med Ctr, Div Hematol Oncol, Los Angeles, CA 90095 USAVogel, Arndt论文数: 0 引用数: 0 h-index: 0机构: Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany UCLA, David Geffen Sch Med, Dept Med,Med Ctr, Div Hematol Oncol, Los Angeles, CA 90095 USAKudo, Masatoshi论文数: 0 引用数: 0 h-index: 0机构: Kindai Univ, Fac Med, Dept Gastroenterol & Hepatol, Osakasayama, Japan UCLA, David Geffen Sch Med, Dept Med,Med Ctr, Div Hematol Oncol, Los Angeles, CA 90095 USA
- [34] PHASE 3 STUDY OF PEMBROLIZUMAB plus BELZUTIFAN plus LENVATINIB OR PEMBROLIZUMAB/QUAVONLIMAB plus LENVATINIB VERSUS PEMBROLIZUMAB plus LENVATINIB AS FIRST-LINE TREATMENT FOR ADVANCED RENAL CELL CARCINOMAJOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A447 - A447论文数: 引用数: h-index:机构:Plimack, Elizabeth论文数: 0 引用数: 0 h-index: 0机构: Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA Dana Farber Canc Inst, Boston, MA USAPowles, Thomas论文数: 0 引用数: 0 h-index: 0机构: Barts Hlth NHS Trust, London, England Royal Free NHS Fdn Trust, London, England Dana Farber Canc Inst, Boston, MA USAVoss, Martin论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Dana Farber Canc Inst, Boston, MA USAGurney, Howard论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Dana Farber Canc Inst, Boston, MA USASilverman, Rachel论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Dana Farber Canc Inst, Boston, MA USAPerini, Rodolfo论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Dana Farber Canc Inst, Boston, MA USARodriguez-Lopez, Karla论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Dana Farber Canc Inst, Boston, MA USARini, Brian论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Ingram Canc Ctr, Nashville, TN USA Dana Farber Canc Inst, Boston, MA USA
- [35] Pembrolizumab/quavonlimab coformulation in combination with lenvatinib in advanced hepatocellular carcinoma: Phase 2 trial in progressANNALS OF ONCOLOGY, 2021, 32 : S144 - S145Li, D.论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA USA City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA USACheng, A.论文数: 0 引用数: 0 h-index: 0机构: Natl Taiwan Univ Hosp, Taipei, Taiwan City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA USALim, H.论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Samsung Med Ctr, Seoul, South Korea City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA USALlovet, J.论文数: 0 引用数: 0 h-index: 0机构: Icahn Sch Med Mt Sinai, New York, NY 10029 USA City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA USAZhu, Y.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA USAHatogai, K.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA USASiegel, A.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA USAKudo, M.论文数: 0 引用数: 0 h-index: 0机构: Kindai Univ, Fac Med, Osaka, Japan City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA USA
- [36] Survival outcomes from atezolizumab plus bevacizumab versus Lenvatinib in Child Pugh B unresectable hepatocellular carcinoma patientsJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (10) : 7565 - 7577Rimini, Margherita论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, Italy IRCCS San Raffaele Hosp, Dept Oncol, Milan, Italy Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyPersano, Mara论文数: 0 引用数: 0 h-index: 0机构: Univ Cagliari, Med Oncol, Cagliari, Italy Univ Hosp Cagliari, Cagliari, Italy Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyTada, Toshifumi论文数: 0 引用数: 0 h-index: 0机构: Japanese Red Cross Himeji Hosp, Dept Internal Med, Himeji, Japan Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, Italy论文数: 引用数: h-index:机构:Shimose, Shigeo论文数: 0 引用数: 0 h-index: 0机构: Kurume Univ, Dept Med, Div Gastroenterol, Sch Med, Fukuoka, Kurume 8300011, Japan Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyKudo, Masatoshi论文数: 0 引用数: 0 h-index: 0机构: Kindai Univ, Fac Med, Dept Gastroenterol & Hepatol, Osakasayama, Japan Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyCheon, Jaekyung论文数: 0 引用数: 0 h-index: 0机构: CHA Univ, CHA Bundang Med Ctr, Dept Med Oncol, Sch Med, Seongnam, South Korea Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyFinkelmeier, Fabian论文数: 0 引用数: 0 h-index: 0机构: Goethe Univ, Univ Hosp Frankfurt, Dept Internal Med 1, Frankfurt, Germany Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyLim, Ho Yeong论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyPresa, Jose论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalySalani, Francesca论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyLonardi, Sara论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyPiscaglia, Fabio论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyKumada, Takashi论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalySakamoto, Naoya论文数: 0 引用数: 0 h-index: 0机构: Japanese Red Cross Himeji Hosp, Dept Internal Med, Himeji, Japan Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyIwamoto, Hideki论文数: 0 引用数: 0 h-index: 0机构: Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, North 15,West 7,Kita Ku, Sapporo, Hokkaido 0608638, Japan Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyAoki, Tomoko论文数: 0 引用数: 0 h-index: 0机构: Kurume Univ, Dept Med, Div Gastroenterol, Sch Med, Fukuoka, Kurume 8300011, Japan Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyChon, Hong Jae论文数: 0 引用数: 0 h-index: 0机构: Kindai Univ, Fac Med, Dept Gastroenterol & Hepatol, Osakasayama, Japan Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyHimmelsbach, Vera论文数: 0 引用数: 0 h-index: 0机构: CHA Univ, CHA Bundang Med Ctr, Dept Med Oncol, Sch Med, Seongnam, South Korea Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalySchirripa, Marta论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyMontes, Margarida论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyVivaldi, Caterina论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalySolda, Caterina论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyHiraoka, Atsushi论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalySho, Takuya论文数: 0 引用数: 0 h-index: 0机构: Japanese Red Cross Himeji Hosp, Dept Internal Med, Himeji, Japan Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyNiizeki, Takashi论文数: 0 引用数: 0 h-index: 0机构: Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, North 15,West 7,Kita Ku, Sapporo, Hokkaido 0608638, Japan Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyNishida, Naoshi论文数: 0 引用数: 0 h-index: 0机构: Kurume Univ, Dept Med, Div Gastroenterol, Sch Med, Fukuoka, Kurume 8300011, Japan Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalySteup, Christoph论文数: 0 引用数: 0 h-index: 0机构: CHA Univ, CHA Bundang Med Ctr, Dept Med Oncol, Sch Med, Seongnam, South Korea Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyHirooka, Masashi论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyKariyama, Kazuya论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyTani, Joji论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyAtsukawa, Masanori论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyTakaguchi, Koichi论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyItobayashi, Ei论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyFukunishi, Shinya论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyTsuji, Kunihiko论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyIshikawa, Toru论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyTajiri, Kazuto论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyOchi, Hironori论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyYasuda, Satoshi论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyToyoda, Hidenori论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyOgawa, Chikara论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyNishimura, Takashi论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyHatanaka, Takeshi论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyKakizaki, Satoru论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyShimada, Noritomo论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyKawata, Kazuhito论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyTada, Fujimasa论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyOhama, Hideko论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, ItalyNouso, Kazuhiro论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, Italy
- [37] Survival outcomes from atezolizumab plus bevacizumab versus Lenvatinib in Child Pugh B unresectable hepatocellular carcinoma patientsJournal of Cancer Research and Clinical Oncology, 2023, 149 : 7565 - 7577Margherita Rimini论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyMara Persano论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyToshifumi Tada论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyGoki Suda论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyShigeo Shimose论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyMasatoshi Kudo论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyJaekyung Cheon论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyFabian Finkelmeier论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyHo Yeong Lim论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyJosé Presa论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyFrancesca Salani论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologySara Lonardi论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyFabio Piscaglia论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyTakashi Kumada论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyNaoya Sakamoto论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyHideki Iwamoto论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyTomoko Aoki论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyHong Jae Chon论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyVera Himmelsbach论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyMarta Schirripa论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyMargarida Montes论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyCaterina Vivaldi论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyCaterina Soldà论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyAtsushi Hiraoka论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyTakuya Sho论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyTakashi Niizeki论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyNaoshi Nishida论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyChristoph Steup论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyMasashi Hirooka论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyKazuya Kariyama论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyJoji Tani论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyMasanori Atsukawa论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyKoichi Takaguchi论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyEi Itobayashi论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyShinya Fukunishi论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyKunihiko Tsuji论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyToru Ishikawa论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyKazuto Tajiri论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyHironori Ochi论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologySatoshi Yasuda论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyHidenori Toyoda论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyChikara Ogawa论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyTakashi Nishimura论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyTakeshi Hatanaka论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologySatoru Kakizaki论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyNoritomo Shimada论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyKazuhito Kawata论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyFujimasa Tada论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyHideko Ohama论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of OncologyKazuhiro Nouso论文数: 0 引用数: 0 h-index: 0机构: Vita-Salute San Raffaele University,Department of Oncology
- [38] Lenvatinib as a therapy for unresectable hepatocellular carcinomaEXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (11) : 1069 - 1076Spallanzani, Andrea论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Modena, Div Oncol, Via Pozzo 71, I-41124 Modena, Italy Univ Hosp Modena, Div Oncol, Via Pozzo 71, I-41124 Modena, ItalyOrsi, Giulia论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Modena, Div Oncol, Via Pozzo 71, I-41124 Modena, Italy Univ Hosp Modena, Div Oncol, Via Pozzo 71, I-41124 Modena, ItalyAndrikou, Kalliopi论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Modena, Div Oncol, Via Pozzo 71, I-41124 Modena, Italy Univ Hosp Modena, Div Oncol, Via Pozzo 71, I-41124 Modena, ItalyGelsomino, Fabio论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Modena, Div Oncol, Via Pozzo 71, I-41124 Modena, Italy Univ Hosp Modena, Div Oncol, Via Pozzo 71, I-41124 Modena, ItalyRimini, Margherita论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Modena, Div Oncol, Via Pozzo 71, I-41124 Modena, Italy Univ Hosp Modena, Div Oncol, Via Pozzo 71, I-41124 Modena, ItalyRiggi, Laura论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Modena, Div Oncol, Via Pozzo 71, I-41124 Modena, Italy Univ Hosp Modena, Div Oncol, Via Pozzo 71, I-41124 Modena, ItalyCascinu, Stefano论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Modena, Div Oncol, Via Pozzo 71, I-41124 Modena, Italy Univ Hosp Modena, Div Oncol, Via Pozzo 71, I-41124 Modena, Italy
- [39] Pembrolizumab plus lenvatinib for radically unresectable or metastatic renal cell carcinoma in the Japanese populationEXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (05) : 461 - 469Fujiwara, Ryo论文数: 0 引用数: 0 h-index: 0机构: Canc Inst Hosp, Japanese Fdn Canc Res, Dept Urol, Tokyo, Japan Canc Inst Hosp, Japanese Fdn Canc Res, Dept Urol, Tokyo, JapanYuasa, Takeshi论文数: 0 引用数: 0 h-index: 0机构: Canc Inst Hosp, Japanese Fdn Canc Res, Dept Urol, Tokyo, Japan Japanese Fdn Canc Res, Canc Inst Hosp, Dept Urol, Tokyo 1358550, Japan Canc Inst Hosp, Japanese Fdn Canc Res, Dept Urol, Tokyo, JapanKobayashi, Kenichi论文数: 0 引用数: 0 h-index: 0机构: Shiga Univ Med Sci, Dept Urol, Seta, Otsu, Japan Canc Inst Hosp, Japanese Fdn Canc Res, Dept Urol, Tokyo, JapanYoshida, Tetsuya论文数: 0 引用数: 0 h-index: 0机构: Shiga Univ Med Sci, Dept Urol, Seta, Otsu, Japan Canc Inst Hosp, Japanese Fdn Canc Res, Dept Urol, Tokyo, JapanKageyama, Susumu论文数: 0 引用数: 0 h-index: 0机构: Shiga Univ Med Sci, Dept Urol, Seta, Otsu, Japan Canc Inst Hosp, Japanese Fdn Canc Res, Dept Urol, Tokyo, Japan
- [40] Lenvatinib plus TACE with or without pembrolizumab for the treatment of initially unresectable hepatocellular carcinoma harbouring PD-L1 expression: a retrospective studyJournal of Cancer Research and Clinical Oncology, 2022, 148 : 2115 - 2125Song Chen论文数: 0 引用数: 0 h-index: 0机构: Sun Yat-Sen University,Department of Interventional Radiology, The First Affiliated HospitalZhiqiang Wu论文数: 0 引用数: 0 h-index: 0机构: Sun Yat-Sen University,Department of Interventional Radiology, The First Affiliated HospitalFeng Shi论文数: 0 引用数: 0 h-index: 0机构: Sun Yat-Sen University,Department of Interventional Radiology, The First Affiliated HospitalQicong Mai论文数: 0 引用数: 0 h-index: 0机构: Sun Yat-Sen University,Department of Interventional Radiology, The First Affiliated HospitalLiguang Wang论文数: 0 引用数: 0 h-index: 0机构: Sun Yat-Sen University,Department of Interventional Radiology, The First Affiliated HospitalFan Wang论文数: 0 引用数: 0 h-index: 0机构: Sun Yat-Sen University,Department of Interventional Radiology, The First Affiliated HospitalWenquan Zhuang论文数: 0 引用数: 0 h-index: 0机构: Sun Yat-Sen University,Department of Interventional Radiology, The First Affiliated HospitalXiaoming Chen论文数: 0 引用数: 0 h-index: 0机构: Sun Yat-Sen University,Department of Interventional Radiology, The First Affiliated HospitalHuanwei Chen论文数: 0 引用数: 0 h-index: 0机构: Sun Yat-Sen University,Department of Interventional Radiology, The First Affiliated HospitalBo Xu论文数: 0 引用数: 0 h-index: 0机构: Sun Yat-Sen University,Department of Interventional Radiology, The First Affiliated HospitalJiaming Lai论文数: 0 引用数: 0 h-index: 0机构: Sun Yat-Sen University,Department of Interventional Radiology, The First Affiliated HospitalWenbo Guo论文数: 0 引用数: 0 h-index: 0机构: Sun Yat-Sen University,Department of Interventional Radiology, The First Affiliated Hospital